The same techniques in analyzing Loxl3 influence on melanoma progression and dissemination were used in a recent study by Vázquez-Naharro on animal models, and it showed that Loxl3 knockout and activation of Braf with concomitant inactivation of Pten reduced melanoma growth, while increasing latency and overall mice survival. Here, BRAF is linked to melanoma.